Botulismo y muerte súbita infantil.

Same author

1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.

Journal of medicinal chemistry·1996

Same author

Evaluation of human cytokine production and effects of pharmacological agents in a heterologous system in vivo.

Journal of immunological methods·1996

Same author

Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke.

Molecular and chemical neuropathology·1995

Same author

Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats.

The Journal of pharmacology and experimental therapeutics·1993

Same author

Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730).

European journal of pharmacology·1993

Same author

ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats.

Journal of applied physiology (Bethesda, Md. : 1985)·1993

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Botulismo y muerte súbita infantil.

Videos de Conceptos Relacionados

1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.

Evaluation of human cytokine production and effects of pharmacological agents in a heterologous system in vivo.

Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke.

Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats.

Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730).

ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

Videos de Experimentos Relacionados

Botulismo y muerte súbita infantil.

Videos de Conceptos Relacionados

Artículos Relacionados

1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.

Evaluation of human cytokine production and effects of pharmacological agents in a heterologous system in vivo.

Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke.

Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats.

Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730).

ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.